Skip to main content

Month: May 2020

12 Exploration and 79North Announce Upsized Offering and Execution of Definitive Agreement

Not for distribution to United States newswire services or for release publication, distribution or dissemination directly, or indirectly, in whole or in part, in or into the United States.TORONTO, May 19, 2020 (GLOBE NEWSWIRE) — 12 Exploration Inc. (CSE: TWLV) (“12Ex”) and 79North Ltd. (“79North”) announce that, as a result of high demand, they have increased the size of the previously announced non-brokered private placement (the “Offering”) of subscription receipts of each of 79North and 12Ex (together, the “Subscription Receipts”) to raise targeted aggregate gross proceeds of approximately C$4,000,000. Other terms of the Offering remain unchanged from those disclosed in the April 30, 2020 news release.79North is led by a team with deep mineral exploration expertise and a track record of discoveries and exits in South America and...

Continue reading

Genocea Announces Material Transfer and License Option Agreement with Shionogi for Proprietary GEN-003 HSV-2 Antigens

CAMBRIDGE, Mass., May 19, 2020 (GLOBE NEWSWIRE) — Genocea Biosciences, Inc. (NASDAQ: GNCA), a biopharmaceutical company developing next-generation neoantigen immunotherapies, today announced it has entered into a material transfer agreement (MTA) and exclusive license option with Shionogi & Co., Ltd. to develop a novel HSV-2 vaccine using Genocea’s proprietary HSV-2 antigens from the GEN-003 program, which the company discontinued in 2017. Under the terms of the agreement, Shionogi will pay $2 million for the exclusive option to evaluate the HSV-2 antigens and to negotiate a license prior to expiration of the MTA. Upon exercise of Shionogi’s option, terms of the license are expected to include an upfront payment, regulatory and sales milestones, as well as tiered royalties. Final terms of the license agreement will be based...

Continue reading

AnalytixInsight’s MarketWall Well Positioned for FinTech Online Usage Surge

TORONTO, May 19, 2020 (GLOBE NEWSWIRE) — Artificial Intelligence company, AnalytixInsight Inc. (“AnalytixInsight”, or the “Company”) (TSX-V: ALY; OTCQB: ATIXF) expects its FinTech affiliate MarketWall will benefit from the surging new trend toward online channels caused by the COVID-19 pandemic, following Intesa Sanpaolo’s Q1 2020 report which witnessed strong online digital channel usage during the quarter.MarketWall develops and sells FinTech online digital solutions for major European financial services firms, including Intesa Sanpaolo. During 2019, MarketWall grew its revenues by 65% to C$6.2 million and net income by 259% to C$1.5 million. MarketWall is 49%-owned by AnalytixInsight and 33%-owned by Intesa Sanpaolo.Excerpts from Intesa Sanpaolo’s Q1 2020 results relating to approximate online digital channel usage during the...

Continue reading

ViraxClear Opens New Markets for Distribution of Test Kits with Distribution Contract in Philippines

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATESVANCOUVER, British Columbia, May 19, 2020 (GLOBE NEWSWIRE) — Global Care Capital Corp. (CSE: HLTH, FRANKFURT: L6V1) (the “Company” or “Global Care”) a global investment company which engages in early stage investment opportunities in private and public companies, is pleased to announce that its portfolio company, ViraxClear, through its joint venture, Shanghai Biotechnology Devices Ltd. (“SBD”) has on May 14th, 2020, finalized an agreement for the distribution of its COVID-19 Rapid Antibody Test Kits (“Test Kits”) for the Philippines.Distribution Contract for Test Kits in PhilippinesViraxClear has signed a contract for distribution of up to 1,000,000 test kits, wherein Philippines medical device distribution company Novarad Asia Pacific...

Continue reading

Cowen Healthcare Investments Successfully Raises $493 Million For Third Fund

NEW YORK, May 19, 2020 (GLOBE NEWSWIRE) — Cowen Healthcare Investments (“CHI”), a private healthcare investment strategy within the investment management division of Cowen Inc. (NASDAQ:COWN), announced today that it has successfully completed fundraising for Cowen Healthcare Investments III LP (“CHI III” or the “Fund”) with $493 million, $93 million above the Fund’s original target. CHI received commitments from existing and new investors, including institutional investors, family offices, and high net worth individuals.Led by Kevin Raidy, Tim Anderson, and Robert Sine, CHI was founded in 2012 to support innovation in the healthcare sector, with a particular focus on biopharma, diagnostics and digital health. CHI focuses its investment activity on established companies with outstanding management teams and...

Continue reading

FTI Consulting Survey Shares Data Privacy Budget and Solutions Forecast

WASHINGTON, May 19, 2020 (GLOBE NEWSWIRE) — FTI Consulting, Inc. (NYSE: FCN) today announced the second set of findings from its Technology segment’s study of data privacy trends. Based on responses from more than 500 leaders of large, U.S.-based companies, Future-Proofing Corporate Data Privacy: Budgeting and Solutions to Address Tomorrow’s Compliance Challenges, provides an outlook for the solutions, strategies and budgets companies have planned to address emerging data privacy challenges in the coming year.The survey reported significant increases in spend and data privacy-related programs. Though respondents are increasing their emphasis on privacy compliance, the results showed that many are also willing to take risks in the interest of tapping into the value of their data. Still others believe that “good faith” efforts will...

Continue reading

New Data at AAN Showcase Biogen’s Commitment to Advancing Innovation in MS

Patients treated with VUMERITY® (diroximel fumarate) and TECFIDERA® (dimethyl fumarate) showed a significant reduction of gadolinium-enhancing lesions compared to baselineAdditional data show improved gastrointestinal tolerability with VUMERITY compared to TECFIDERAFurther research evaluates extended interval dosing with TYSABRI® (natalizumab) compared to the currently approved dosing regimenCAMBRIDGE, Mass., May 19, 2020 (GLOBE NEWSWIRE) — Biogen Inc. (Nasdaq: BIIB) today announced new data from its robust multiple sclerosis (MS) treatment portfolio. Additional clinical data support VUMERITY® (diroximel fumarate) as an important oral treatment option in relapsing MS and reinforce the efficacy of TECFIDERA® (dimethyl fumarate). In addition, an analysis of TYSABRI® (natalizumab) contributes to data demonstrating the reduced risk...

Continue reading

Spices and Seasonings Market Size Worth USD 22.87 Billion by 2026; Increasing Awareness about Medicinal Properties of Spices will Aid in Expansion of Market, says Fortune Business Insights™

Pune, May 19, 2020 (GLOBE NEWSWIRE) — The global spices and seasonings market size is projected to gain impetus from the increasing popularity of ethnic cuisines all across the world. Spices and seasonings are ingredients that enhance the flavor, and color of the food. It also helps to preserves cooked food for a longer time. Spices are derived from various natural sources such as the bark of trees, fruits, flowers, seeds, buds, leaves, roots, and others. A recent report by Fortune Business Insights titled, “Spices and Seasonings Market Size, Share & Industry Analysis, By Type (Pepper, Chili, Ginger, Cinnamon, Cumin, Turmeric, Nutmeg and Mace, Cardamom, Cloves, and Others), Application (Meat and Poultry, Bakery and Confectionery, Frozen Food, Snacks and Convenience Food, and Others), and Regional Forecasts 2019-2026,” discusses...

Continue reading

Palomar Holdings, Inc. Announces the Successful Completion of Reinsurance Programs

LA JOLLA, Calif., May 19, 2020 (GLOBE NEWSWIRE) — Specialty property insurer Palomar Holdings, Inc. (NASDAQ: PLMR) (‘Palomar’ or the ‘Company’) today announced the successful completion of certain reinsurance programs incepting at June 1, 2020.The Company procured approximately $200 million of incremental limit for California earthquakes, approximately $300 million of incremental limit for all earthquake zones, and approximately $80 million of incremental windstorm limit. Reinsurance coverage now exhausts at $1.4 billion for earthquake events and $600 million for hurricane events, providing adequate headroom to support the Company’s growth initiatives as well as coverage in excess of Palomar’s 1:250 year zone peak zone Probable Maximum Loss (“PML”).The Company increased its catastrophe event retention from $5 million to $10 million...

Continue reading

VSBLTY/RADARAPP EXPAND LATIN AMERICAN SMART CITY SECURITY PROGRAM TO COLOMBIA

Philadelphia, PA, May 19, 2020 (GLOBE NEWSWIRE) — The “Smart City” security program that is having continuing success in reducing crime in Mexico City is now being deployed in Colombia, South America. VSBLTY Groupe Technologies Corp. (CSE: VSBY) (Frankfurt: 5VS) (OTC: VSBGF), a leading retail software and technology company, and RadarApp, a Smart City Solutions provider, are now installing and testing the initial phase of a network of security kits in the regions of Bogota, Medellin, and Barranquilla, Colombia consisting of outdoor mounted HD cameras, high intensity lighting, motion sensors and audible alarms as well as VSBLTY AI-inspired video analytics.To date, more than 3000 security systems have been installed throughout Mexico City and the success of this cost-efficient technology platform in reducing crime has sparked the interest...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.